(TOKE) Cambria Cannabis - Overview
Etf: Cannabis, ETF, Swaps, Equity
Dividends
| Dividend Yield | 0.97% |
| Yield on Cost 5y | 0.29% |
| Yield CAGR 5y | -40.27% |
| Payout Consistency | 77.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.3% |
| Relative Tail Risk | -15.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.46 |
| Alpha | 6.58 |
| Character TTM | |
|---|---|
| Beta | 0.487 |
| Beta Downside | 0.571 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.91% |
| CAGR/Max DD | -0.04 |
Description: TOKE Cambria Cannabis December 31, 2025
The Cambria Cannabis ETF (BATS:TOKE) is an actively managed U.S. exchange-traded fund that targets total return by holding equity positions in cannabis-related companies and employing total-return swaps to augment exposure to the same sector.
Key metrics to watch include the fund’s expense ratio (currently 0.70% annualized), its 30-day net asset flow (≈ $12 M in-flow as of the latest filing), and the concentration of holdings-over 40% of assets are allocated to the top three U.S. growers, reflecting the sector’s high-beta, low-diversification profile. The primary economic drivers are evolving state-level legalization timelines, federal policy risk, and the pace of ancillary product development (e.g., vaping and biotech extracts), all of which can cause rapid shifts in revenue forecasts for the underlying companies.
For a deeper quantitative breakdown and scenario analysis, you may find ValueRay’s interactive dashboards useful.
What is the price of TOKE shares?
Over the past week, the price has changed by +1.47%, over one month by -3.69%, over three months by +4.61% and over the past year by +16.19%.
Is TOKE a buy, sell or hold?
What are the forecasts/targets for the TOKE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.2 | 6.3% |
TOKE Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 19.6m USD (19.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 19.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 19.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.71% (E(19.6m)/V(19.6m) * Re(7.71%) + (debt-free company))
Discount Rate = 7.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)